The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Abstract
Peripheral blood progenitor cells (PBPCs) are increasingly used for autografting after high-dose chemotherapy. One advantage of PBPCs over the use of autologous bone marrow would be a reduced risk of tumor-cell contamination. However, the actual level of tumor cells contaminating PBPC harvests is poorly investigated. It is currently not known whether mobilization of PBPCs might also result in mobilization of tumor cells. We evaluated 358 peripheral blood samples from 46 patients with stage IV or high-risk stage II/III breast cancer, small cell (SCLC) or non- small cell (NSCLC) lung cancer, as well as other advanced malignancies for the detection of epithelial tumor cells. Monoclonal antibodies against acidic and basic cytokeratin components and epithelial antigens (HEA) were used in an alkaline phosphatase-anti-alkaline phosphatase assay with a sensitivity of 1 tumor cell within 4 x 10(5) total cells. Before initiation of PBPC mobilization, circulating tumor cells were detected in 2/7 (29%) patients with stage IV breast cancer and in 2/10 (20%) patients with extensive-disease SCLC, respectively. In these patients, an even higher number of circulating tumor cells was detected after chemotherapy with VP16, ifosfamide, and cisplatin (VIP) followed by granulocyte colony-stimulating factor (G-CSF). This approach has previously been shown to be highly effective in mobilizing PBPCs. In the 42 patients without circulating tumor cells during steady state, tumor cells were mobilized in 9/42 (21%) patients after VIP+G-CSF induced recruitment of PBPCs. The overall incidence of tumor cells varied between 4 and 5,600 per 1.6 x 10(6) mononuclear cells analyzed. All stage IV breast cancer patients and 50% of SCLC patients were found to concomitantly mobilize tumor cells and PBPCs. Kinetic analyses showed two patterns of tumor cell recruitment depending on the presence or absence of bone marrow disease: (1) early after chemotherapy (between days 1 and 7) in patients without marrow infiltration, and (2) between days 9 and 16 in patients with marrow infiltration, ie, within the optimal time period for the collection of PBPCs. We show that there is a high proportion of patients with circulating tumor cells under steady-state conditions, and in addition a substantial risk of concomitant tumor cell recruitment upon mobilization of PBPCs, particularly in stage IV breast cancer patients with bone marrow infiltration. The biologic and clinical significance of this finding is unknown at present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
Brenner, M. K., Rill, D. R., Krance, R. A., Ihle, J. N., Moen, R. C., Mirro, J., & Anderson, W. F. (1993) · The Lancet · doi:10.1016/0140-6736(93)92560-g · Cited by 893
Sheridan, W. P., Fox, R. M., Begley, C. G., Maher, D., McGrath, K. M., Begley, C. G., Juttner, C. A., To, L. B., Szer, J., & Mostyn, G. (1992) · The Lancet · doi:10.1016/0140-6736(92)90795-5 · Cited by 857
Gianni, A., Bregni, M., Stern, A., Siena, S., Tarella, C., Pileri, A., & Bonadonna, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90711-3 · Cited by 740
Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111283252201 · Cited by 668
Duhrsen, U., Villeval, J., Boyd, J., Kannourakis, G., Morstyn, G., & Metcalf, D. (1988) · Blood · doi:10.1182/blood.v72.6.2074.2074 · Cited by 584
Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
Lindemann, F., Witte, J., Schlimok, G., Dirschedl, P., & Riethmuller, G. (1992) · The Lancet · doi:10.1016/0140-6736(92)92230-d · Cited by 544
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma
Berenson, R., Bensinger, W., Hill, R., Andrews, R., Garcia-Lopez, J., Kalamasz, D., Still, B., Spitzer, G., Buckner, C., & Bernstein, I. (1991) · Blood · doi:10.1182/blood.v77.8.1717.1717 · Cited by 519
Ross, A., Cooper, B., Lazarus, H., Mackay, W., Moss, T., Ciobanu, N., Tallman, M., Kennedy, M., Davidson, N., & Sweet, D. (1993) · Blood · doi:10.1182/blood.v82.9.2605.2605 · Cited by 488
Brugger, W., Mocklin, W., Heimfeld, S., Berenson, R., Mertelsmann, R., & Kanz, L. (1993) · Blood · doi:10.1182/blood.v81.10.2579.2579 · Cited by 307
Self-citationKessinger, A., & Armitage, J. (1991) · Blood · doi:10.1182/blood.v77.2.211.211 · Cited by 294
Cited by
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542
Challenges in circulating tumour cell research
Alix-Panabières, C., & Pantel, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3820 · Cited by 1,300
Ozer, H., Armitage, J. O., Bennett, C. L., Crawford, J., Demetri, G. D., Pizzo, P. A., Schiffer, C. A., Smith, T. J., Somlo, G., Wade, J. C., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3558 · Cited by 1,044
The Biology of Hematopoietic Stem Cells
Morrison, S. J., Uchida, N., & Weissman, I. L. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.000343 · Cited by 778
Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells
Körbling, M., Katz, R. L., Khanna, A., Ruifrok, A. C., Rondon, G., Albitar, M., Champlin, R. E., & Estrov, Z. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa3461002 · Cited by 757
Metadata
- Authors
- Brugger, W., Bross, K., Glatt, M., Weber, F., Mertelsmann, R., & Kanz, L.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1994-02-01
- Volume
- 83
- Issue
- 3
- Pages
- 636-640
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W3112391997
- Cited by
- 442
- References
- 13
- FWCI
- 38.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]. https://app.cochat.ai/papers/10.1182/blood.v83.3.636.636
- The paper
- Brugger, W., Bross, K., Glatt, M., Weber, F., Mertelsmann, R., & Kanz, L. (1994). Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]. Blood. https://doi.org/10.1182/blood.v83.3.636.636
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.